New Products

PITTSBURGH — Mylan and Orion Corp. have settled a patent-infringement suit over a drug used to treat Parkinson's disease, Mylan said Thursday.

The generic drug maker had filed with the Food and Drug Administration for a generic version of Orion's Stalevo (carpidopa; levodopa; entacapone) tablets, used to treat idiopathic Parkinson's to substitute for immediate-release carbidopa/levodopa and entacapone administered separately.

MIAMI — A new program in south Florida will provide health care for children in underserved communities using mobile telemedicine.

The Children's Health Fund and Verizon Foundation announced the launch of the first "telemedicine clinics on wheels," connecting children to specialists at the University of Miami Miller School of Medicine. Fifteen of the mobile clinics will be equipped with the latest health information technology from the Verizon Foundation.

SOLON, Ohio — Lean Cuisine announced today a new line of entrées made with 100% all-natural ingredients and containing no preservatives.

New Lean Cuisine Honestly Good meals feature six varities containing lean proteins like whole white meat chicken breasts and North Pacific fish filets, whole grains and farm-selected vegetables. Each variety comes with a sauce that can be added in separately.

NEW YORK — Focal Upright Furniture announced on Tuesday the introduction of its newest ergonomic product innovation: the Mogo.

MISSISSAUGA, Ontario — Canadian regulators have approved two drugs made by GlaxoSmithKline for treating skin cancer, GSK said Wednesday.

The drug maker announced Health Canada's approval of Tafinlar (dabrafenib mesylate) and Mekinist (trametinib) in patients with melanoma that can't be removed by surgery or has spread to other parts of the body.

FREMONT, Neb. — Natura Pet Products and its flagship brand Innova have announced a new line of Farmhouse Stews for pet parents who want to enhance their dogs’ meals with an alternative to dry food.

COLUMBUS, Ohio — Prior-authorization software company CoverMyMeds reached a milestone Tuesday as the 5 millionth PA request was sent through its system.

CoverMyMeds said the announcement came a day after the National Council for Prescription Drug Programs published the first e-prescribing standard to include the electronic PA implementation guide. CoverMyMeds has worked with the industry to develop the standard and said it was the first provider software vendor to use the standard at scale.

MUMBAI, India — The Food and Drug Administration has approved a generic diabetes drug made by Lupin, the company said.

Lupin, based in India, received approval for metformin hydrochloride extended-release tablets in the 500-mg and 1,000-mg strengths. The drug is a generic version of Santarus' Glumetza.

Glumetza had sales of about $144 million during the 12-month period that ended in March, according to IMS Health. The drug is an extended-release formulation of metformin hydrochloride, a widely prescribed drug used for treating Type 2 diabetes.